Regions Financial Corporation
—- Market cap
- $25.92B
- Debt
- +$4.88B
- Cash
- —
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 84% equity / 16% debt
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: RF stock price vs NEO: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at NEO's multiple
Needs NEO P/E.
Implied fair value · at RF's multiple
Needs EPS (TTM) is negative, RF P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RF FY 2025 (ended Dec 31, 2025) · NEO FY 2025 (ended Dec 31, 2025).
Trendline
Nine fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 84% equity / 16% debt
Capital structure 87% equity / 13% debt · EV / Revenue 3.32x
RF carries the larger enterprise value at $30.80B against $2.42B; NEO trades on the lower EV / Revenue multiple (3.32x vs 4.35x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Regions Financial Corporation · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
NeoGenomics, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.26x
0.41x
Net debt / EBITDA
Leverage against operating earnings
—
-4.48x
Cash and equivalents
Liquid reserves on the balance sheet
—
$159.62M
Total debt
Interest-bearing obligations outstanding
$4.88B
$341.86M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JPMorgan Chase & Co.
RF vs JPM
Bank of America Corporation
RF vs BAC
Wells Fargo & Company
RF vs WFC
Citigroup Inc.
RF vs C
The Goldman Sachs Group, Inc.
RF vs GS
Morgan Stanley
RF vs MS
LABCORP HOLDINGS INC.
RF vs LH
QUEST DIAGNOSTICS INC
RF vs DGX
OPKO HEALTH, INC.
RF vs OPK
Guardant Health, Inc.
RF vs GH
Natera, Inc.
RF vs NTRA
EXACT SCIENCES CORP
RF vs EXAS
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.